Physician profile
Mark Anthony Mitchell
NPI 1881660157
$14,757.15
in general payments reported to CMS, 2019-2025
31 companies · $819 in 2025
The $819 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,655 · 2020: $531 · 2021: $868 · 2022: $1,278 · 2023: $1,536 · 2024: $2,070 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,523 · Travel and Lodging: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,522.61 |
| Travel and Lodging | $902.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $4,098.51 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $3,685.37 | 2019-2025 | Watchman Access System, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,277.61 | 2021-2025 | Micra, Linq II, Selectsecure |
| Novartis Pharmaceuticals Corporation | $660.49 | 2019-2025 | |
| Amgen INC. | $592.35 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $579.15 | 2019-2025 | Edora 8 Dr-T, Solia, Acticor 7 Vr-T Dx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $479.76 | 2019-2025 | Jardiance |
| Cvrx, INC. | $427.64 | 2022-2024 | Barostim Neo System |
| Abbott Laboratories | $355.70 | 2019-2025 | Mitraclip, Jot Dx, Assurity |
| Cardiva Medical, INC. | $337.12 | 2021-2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $310.81 | 2020-2024 | Lifevest |
| Medtronic Vascular, INC. | $291.64 | 2019-2020 | |
| Philips North America LLC | $282.40 | 2024 | (Ck4) Mcot, (Cm9) Amb Mon & Diag Und |
| Astrazeneca Pharmaceuticals Lp | $280.85 | 2019-2025 | Lokelma, Farxiga, Wainua |
| Vital Connect, INC | $215.60 | 2023-2025 | Vitalpatch Rtm |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $149.57 | 2019-2024 | Xarelto |
| Atricure, INC. | $111.61 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $111.30 | 2019-2024 | |
| Biosense Webster, INC. | $110.86 | 2022-2025 | Nuvision Ice Catheter, Carto 3 |
| Novo Nordisk INC | $108.10 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $78.48 | 2021-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $58.01 | 2023 | |
| Inari Medical, INC. | $29.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Otsuka America Pharmaceutical, INC. | $24.83 | 2019 | |
| Elutia, INC. | $19.07 | 2025 | Ecm Patch,Pouch |
| Chiesi USA, INC. | $18.96 | 2024 | Cleviprex, Kengreal |
| Impulse Dynamics (USA) INC. | $16.65 | 2022 | |
| Portola Pharmaceuticals, LLC | $15.45 | 2020 | |
| Altathera Pharmaceuticals LLC | $15.15 | 2025 | Sotalol Hydrochloride |
| Alnylam Pharmaceuticals INC. | $14.16 | 2025 | Onpattro |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.